MediPharm Labs Corp. (MEDIF)
- Previous Close
0.0648 - Open
0.0620 - Bid 0.0648 x --
- Ask 0.0653 x --
- Day's Range
0.0612 - 0.0683 - 52 Week Range
0.0370 - 0.0850 - Volume
399,154 - Avg. Volume
125,516 - Market Cap (intraday)
26.723M - Beta (5Y Monthly) --
- PE Ratio (TTM)
-- - EPS (TTM)
-0.0200 - Earnings Date Aug 12, 2025 - Aug 18, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
MediPharm Labs Corp. operates as a pharmaceutical company that produces and sells purified, pharmaceutical-quality cannabis extracts, concentrates, active pharmaceutical ingredients, and advanced derivative products in Canada, Australia, Germany, and internationally. The company formulates, develops, processes, packages, and distributes cannabis active ingredients and advanced cannabinoid-based products. It also provides good manufacturing practice flower sourcing, packaging, and distribution services, as well as dried flower and pre-roll cannabis products. In addition, the company offers cannabis related medical information and services; and medical cannabis clinic services. MediPharm Labs Corp. was founded in 2015 and is based in Barrie, Canada.
www.medipharmlabs.com161
Full Time Employees
December 31
Fiscal Year Ends
Sector
Recent News: MEDIF
View More
Performance Overview: MEDIF
Trailing total returns as of 5/16/2025, which may include dividends or other distributions. Benchmark is S&P/TSX Composite index (^GSPTSE) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: MEDIF
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: MEDIF
View MoreValuation Measures
Market Cap
26.51M
Enterprise Value
18.41M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
0.88
Price/Book (mrq)
0.86
Enterprise Value/Revenue
0.61
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
-17.37%
Return on Assets (ttm)
-6.04%
Return on Equity (ttm)
-16.05%
Revenue (ttm)
43M
Net Income Avi to Common (ttm)
-7.47M
Diluted EPS (ttm)
-0.0200
Balance Sheet and Cash Flow
Total Cash (mrq)
8.44M
Total Debt/Equity (mrq)
0.29%
Levered Free Cash Flow (ttm)
-6.59M